In the Senate since February 18, 2026.
2026 Regular Session
Senate Bill 227
AN ACT ESTABLISHING A TASK FORCE TO STUDY OVER-THE-COUNTER DIET PILLS AND SUPPLEMENTS AND PROTECT THE PRIVACY OF PRESCRIBERS OF PRESCRIPTION DRUGS FOR REPRODUCTIVE HEALTH CARE AND GENDER-AFFIRMING HEALTH CARE.
What it does
The synopsis the General Assembly published with the bill.
To prohibit marketing of certain weight loss pills and supplements to minors and enact legal and privacy protections for prescribers of prescription drugs for reproductive and gender-affirming health care.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
1 co-sponsor
In the House of Representatives
2 co-sponsors
Its course
February 18 to March 30, 2026, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Feb 18 – Mar 16
- Feb 18Introduced and sent to General Law Committee
- Feb 19Heard in General Law Committee
- Mar 16General Law Committee recommended a substitute for it
All 9 actions, as published
- Feb 18REF. TO JOINT COMM. ONBoth houses
- Feb 19PUBLIC HEARINGBoth houses
- Mar 16Joint Favorable SubstituteBoth houses
- Mar 17FILED WITH LCOBoth houses
- Mar 23REFERRED TO OLR, OFABoth houses
- Mar 30RPTD. OUT OF LCOBoth houses
- Mar 30FAV. RPT., TAB. FOR CAL., SEN.Senate
- Mar 30SENATE CALENDAR NUMBERSenate
- Mar 30FILE NO.Both houses